Establishing a robust and intimate mucosal interface that allows medical devices to remain within lumen-confined organs for extended periods has valuable applications, particularly for gastrointestinal theranostics. Here, we report the development of an electroadhesive hydrogel interface for robust and prolonged mucosal retention after electrical activation (e-GLUE). The e-GLUE device is composed of cationic polymers interpenetrated within a tough hydrogel matrix. An e-GLUE electrode design eliminated the need for invasive submucosal placement of ground electrodes for electrical stimulation during endoscopic delivery. With an electrical stimulation treatment of about 1 minute, the cationic polymers diffuse and interact with polyanionic proteins that have a relatively slow cellular turnover rate in the deep mucosal tissue. This mucosal adhesion mechanism increased the adhesion energy of hydrogels on the mucosa by up to 30-fold and enabled in vivo gastric retention of e-GLUE devices in a pig stomach for up to 30 days. The adhesion strength was modulated by polycationic chain length, electrical stimulation time, gel thickness, cross-linking density, voltage amplitude, polycation concentration, and perimeter-to-area ratio of the electrode assembly. In porcine studies, e-GLUE demonstrated rapid mucosal adhesion in the presence of luminal fluid and mucus exposure. In proof-of-concept studies, we demonstrated e-GLUE applications for mucosal hemostasis, sustained local delivery of therapeutics, and intimate biosensing in the gastrointestinal tract, which is an ongoing clinical challenge for commercially available alternatives, such as endoclips and mucoadhesive. The e-GLUE platform could enable theranostic applications across a range of digestive diseases, including recurrent gastrointestinal bleeding and inflammatory bowel disease.
Diagnosing and treating small intestinal disorders such as bleeding, inflammatory bowel disease, and tumors present challenges because of limited access to this anatomical compartment. We present BIOSENTER, a bioinspired soft enteroscopic robot for deep procedures in the small intestine that addresses locomotion, steering, and intervention constraints of existing soft robotic systems. BIOSENTER features a hollow cylinder architecture comprising a linearly deformable soft pneumatic actuator as the body, two radially expandable soft pneumatic actuators wrapped with kirigami sleeves as the head and tail, a central hollow channel for accessory endoscopic tools, and a control box for navigation. Inspired by snake locomotion, the robotic body incorporates a fiber-reinforced actuator with four embedded inflatable chambers, enabling steering and axial expansion. The dynamic kirigami sleeves generate an anchoring force of ∼1.5 newtons on intestinal mucosa while requiring substantially less radial expansion than the corresponding nonkirigami configuration. A reinforced central channel supports tool passage for diagnostic and therapeutic interventions. The control box enables locomotion and steering at autonomous speeds of ∼100 millimeters per minute in vitro and ∼43 millimeters per minute in tissue-covered tubing. BIOSENTER successfully navigated the collapsed, tortuous small intestine for 2 meters in 11 minutes, with gentle forward pushing forces of 2.2 to 6.4 newtons in pig studies. In vivo pig studies demonstrated technical feasibility of tissue biopsy, localized fluid delivery as a model for future drug administration, and real-time visualization of the deep intestine, without macroscopic overdistention or visible tissue damage under the tested conditions.